• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·France·Consumer Cyclical·ALDAR.PA
Share

Damartex Stocks

€ 2.27Last Updated 26.05.2026

Issuer Rating

3/7
Performance

Average

Risk

Considerable

Recommendation

Sell

Market Cap

€ 30.07M

€ 2.27
Key Takeaways

Risk factor

Very poor trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Undervalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Latest news

04.03.2026 16:05

Limit down: what is happening in the UAE

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Damartex offers clothing and accessories for seniors primarily in France, the Great-Britain, Belgium, and Germany. It operates in three divisions: Fashion, Home & Lifestyle, and Healthcare. It offers its fashion products under the Damart, Afibel, La Maison du Jersey, and Xandres brands; home and lifestyle products under the 3Pagen, Vitrine Magique, Coopers of Stortford, Jours Heureux, and Delaby brands; and healthcare products under the Sedagyl and Santéol brands. Damartex markets its products through catalogs, stores, and Websites. The company was formerly known as Damart SA and changed its name to Damartex in 2002. Damartex was founded in 1953 and is headquartered in Roubaix, France. Damartex is a subsidiary of JPJ-D.

Company Valuation

Undervalued
6/7

Based on key historical and expected multiples, the stock is undervalued relative to its peers. Specifically, the stock is overvalued on EV/EBITDA, underpriced on P/FC.

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Somewhat favourable
5/7

The average target price of ALDAR.PA is 2.7 and suggests 19% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to inc

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

28.05.2026 16:55

Micro-cap company Astrotech rose 460% in just one day. It's targeting the moon

28.05.2026 16:34

UBS: The world's richest families are reducing their investments in the dollar. Where are they going?

28.05.2026 15:58

Morning in New York: geopolitics and macro statistics sway volatility

28.05.2026 15:12

Traders are upping the ante against small-cap companies. What do they fear?

28.05.2026 14:10

Nebius shares soared: its shareholder turned out to be an important AI investor who worked at OpenAI

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn
  • X (Twitter)
  • LinkedIn
Oninvest© 2026